Francesca Rui

Prof. Dr. Francesca Rui

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2010 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
FRFrancesca Rui
Francesca Rui
MBMassimo Bovenzi
Massimo Bovenzi
APAndrea Prodi
Andrea Prodi
Anna Belloni FortinaAnna Belloni Fortina
Anna Belloni Fortina
IRIlaria Romano
Ilaria Romano
FFFrancesca Larese Filon
Francesca Larese Filon

2 July 2012 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
FRFrancesca Rui
Francesca Rui
MBMassimo Bovenzi
Massimo Bovenzi
APAndrea Prodi
Andrea Prodi
Anna Belloni FortinaAnna Belloni Fortina
Anna Belloni Fortina
IRIlaria Romano
Ilaria Romano
FFFrancesca Larese Filon
Francesca Larese Filon

12 May 2012 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
FRFrancesca Rui
Francesca Rui
MBMassimo Bovenzi
Massimo Bovenzi
APAndrea Prodi
Andrea Prodi
Anna Belloni FortinaAnna Belloni Fortina
Anna Belloni Fortina
IRIlaria Romano
Ilaria Romano
FFFrancesca Larese Filon
Francesca Larese Filon

22 September 2007 in International Archives of Occupational and Environmental Health
Verified
Journal Article
Closed access
PDF file
CNCorrado Negro
Corrado Negro
FRFrancesca Rui
Francesca Rui
FDFlavia D’aGostin
Flavia D’aGostin
MBMassimo Bovenzi
Massimo Bovenzi

21 September 2007 in International Archives of Occupational and Environmental Health
Verified
Journal Article
Closed access
PDF file
FRFrancesca Rui
Francesca Rui
FDFlavia D’aGostin
Flavia D’aGostin
CNCorrado Negro
Corrado Negro
MBMassimo Bovenzi
Massimo Bovenzi

8 August 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
CVConcepción Violán
Concepción Violán
LRLucía A. Carrasco Ribelles
Lucía A. Carrasco Ribelles
GCGiulia Collatuzzo
Giulia Collatuzzo
GDGiorgia Ditano
Giorgia Ditano
MAMahsa Abedini
Mahsa Abedini
Pere Torán-MonserratPere Torán-Monserrat
Pere Torán-Monserrat
Understanding antibody persistence concerning multimorbidity is crucial for vaccination policies. Our goal is to assess the link between multimorbidity and serological response to SARS-CoV-2 nine months post-first vaccine. We analyzed Healthcare Workers (HCWs) from three cohorts from Italy, and one each from Germany, Romania, Slovakia, and Spain. Seven groups of chronic diseases were analyzed. We included 2941 HCWs (78.5% female, 73.4% ≥ 40 years old). Multimorbidity was present in 6.9% of HCWs. The prevalence of each chronic condition ranged between 1.9% (cancer) to 10.3% (allergies). Two regression models were fitted, one considering the chronic conditions groups and the other considering whether HCWs had diseases from ≥2 groups. Multimorbidity was present in 6.9% of HCWs, and higher 9-months post-vaccine anti-S levels were significantly associated with having received three doses of the vaccine (RR = 2.45, CI = 1.92–3.13) and with having a prior COVID-19 infection (RR = 2.30, CI = 2.15–2.46). Conversely, lower levels were associated with higher age (RR = 0.94, CI = 0.91–0.96), more time since the last vaccine dose (RR = 0.95, CI = 0.94–0.96), and multimorbidity (RR = 0.89, CI = 0.80–1.00). Hypertension is significantly associated with lower anti-S levels (RR = 0.87, CI = 0.80–0.95). The serological response to vaccines is more inadequate in individuals with multimorbidity.